GENE

BPD (n=10)

MDD (n=13)

p value^{A}

η2


APP

7.63E01± 4.80E02

5.98E01 ± 4.33E02

0.006

0.303

CREB1

7.40E01 ± 4.75E02

6.39E01 ± 2.15E02

0.028

0.210

NFKB1

5.81E01 ± 2.42E02

5.29E01 ± 1.99E02

0.038

0.179

NR3C1

3.27E01 ± 2.81E02

2.78E01 ± 9.51E03

0.043

0.191

SPARC

3.20E+00 ± 2.72E01

2.29E+00 ± 1.80E01

0.003

0.300

TNF

1.36E01 ± 5.99E03

1.68E01 ± 1.14E02

0.032

0.200

 Raw data is displayed in the table. Expressed in scientific notation units where E+00 = x1, E01 = x0.1, E02 = x0.01, etc. Data were log transformed prior to analysis.

^{A}BPD vs. MDD using 5 factor regression model with inclusion of age, QIDSSR, anticonvulsant use, and antidepressant/antipsychotic use. Model has 23 patients, 5 variables, results in 17 degrees of freedom.
 p value is for effect of Diagnostic subgroup after adjusting for the effects of the other 4 factors.
 Effect sizes using η2 for where diagnostic subgroup was significant in the regression model were consistently large (>0.14).